| Kristine Busse Zitelli, MD | |
|
5298 Socialville Foster Rd, Mason, OH 45040-9302 | |
| (513) 770-4212 | |
| (513) 770-4213 |
| Full Name | Kristine Busse Zitelli |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 13 Years |
| Location | 5298 Socialville Foster Rd, Mason, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275824641 | NPI | - | NPPES |
| 0101741 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35.125434 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Dermatology Group Inc | 6406740141 | 19 |
News Archive
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
Children and adolescents with multisystem inflammatory syndrome in children (MIS-C) who are treated initially with intravenous immune globulin (IVIG) and glucocorticoids have reduced risk for serious short-term outcomes, including cardiovascular dysfunction, than those who receive an initial treatment of IVIG alone, a new study finds.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
› Verified 2 days ago
| Entity Name | The Dermatology Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780617860 PECOS PAC ID: 6406740141 Enrollment ID: O20040212000202 |
News Archive
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
Children and adolescents with multisystem inflammatory syndrome in children (MIS-C) who are treated initially with intravenous immune globulin (IVIG) and glucocorticoids have reduced risk for serious short-term outcomes, including cardiovascular dysfunction, than those who receive an initial treatment of IVIG alone, a new study finds.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristine Busse Zitelli, MD 5298 Socialville Foster Rd, Mason, OH 45040-9302 Ph: (513) 770-4212 | Kristine Busse Zitelli, MD 5298 Socialville Foster Rd, Mason, OH 45040-9302 Ph: (513) 770-4212 |
News Archive
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
Children and adolescents with multisystem inflammatory syndrome in children (MIS-C) who are treated initially with intravenous immune globulin (IVIG) and glucocorticoids have reduced risk for serious short-term outcomes, including cardiovascular dysfunction, than those who receive an initial treatment of IVIG alone, a new study finds.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
› Verified 2 days ago
Samir B Patel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5298 Socialville Foster Rd, Mason, OH 45040 Phone: 513-770-4212 Fax: 513-770-4213 | |
Elizabeth E. Uhlenhake, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5298 Socialville Foster Rd, Mason, OH 45040 Phone: 513-770-4212 Fax: 513-770-4213 | |
Mona Datta Mislankar, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4834 Socialville Foster Rd Ste 20, Mason, OH 45040 Phone: 513-459-1988 | |
Dr. Nathan Michael Weir, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5160 Socialville Foster Rd, Mason, OH 45040 Phone: 513-770-3263 | |
Jessica Caraway Perkins, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5298 Socialville Foster Rd, Mason, OH 45040 Phone: 513-770-4212 |